Study: Newer hypertension drugs cut risk of diabetes

09/6/2006 | Reuters

A new analysis of a major European study indicates patients given a mix of newer blood pressure drugs are one-third less likely to develop diabetes than those on older medicines. The study compared a regimen of a beta blocker and a diuretic with a combination of Pfizer's more recent Norvasc, a calcium channel blocker, and Coversyl, an ACE inhibitor developed by France's Servier and marketed in the U.S. Aceon.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Foster City, CA
Sr. Compliance Director Ethics and Compliance
Fridley, MN
Product Patent Attorney
Foster City, CA
Employment Counsel
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC